NIFTY  9,119.40  -0.19%
  SENSEX  29,365.30  -0.19%
 CURRENCY  Rs  64.61/$ 69.32/€, 82.81/£
  GOLD  29,384.00  0.30%
  SILVER  41,269.00  -0.57%
  DAX  12,048.60  0.18%
  FTSE  7,114.55  -0.06%
  CAC  5,059.20  -0.32%
  HANG SENG  24,042.00  -0.06%
  NIKKEI  18,620.80  1.03%
  Shanghai Composite  3,173.15  0.02%
  DOW JONES  20,547.80  -0.15%
  NASDAQ  5,910.52  -0.11%
  S&P 500  2,348.69  -0.30%
FROM ANI - Bank Of India Bulding Catches Fire In Fort Area, Mumbai SPICEJET - Launches Second Daily Direct Flight Between Kolkata-Dhaka

Sun Pharma-Ranbaxy $4 Bn All-Stock Deal

Video:

Play this video

April 7: Ranbaxy stock has been under severe stress today after Sun Pharma agreed to buy the company in a $4 billion all-stock deal. Ranbaxy investors will get 0.8 share in Sun Pharma for every one of their shares. The deal makes Sun the largest pharma company in India and gives it control over Ranbaxy's pipeline of generic products. Speaking to Bloomberg TV India the management also stressed that they see huge value for Ranbaxy shareholder.